Rheumatoid Arthritis Trial, Recruiting NCT06955481 Sponsor: Aesculap AG Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Rheumatoid Arthritis Trial, Recruiting

NCT06955481
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been assessed as needing a total knee replacement surgery using a specific system called the OrthoPilot® Navigation System with an Aesculap knee prosthesis
  • People who are willing and able to sign a consent form agreeing to take part in the study
  • People who are willing and mentally able to attend follow-up check-ups over the long term

Who may not be able to join:

  • People who are pregnant
  • People who are younger than 18 years old or older than 80 years old
  • People who are unable to attend follow-up appointments, whether due to physical or mental reasons
  • People who have already had a joint replacement in the same knee being considered for this study
  • People whose overall health is rated as seriously or critically poor — specifically, those with a severe health condition that significantly limits daily functioning, a life-threatening illness, or who are not expected to survive without surgery (this relates to a standard health rating scale used by doctors; confirm with trial site if unsure which category applies)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jörg Lützner, Prof. Dr., Universitätsklinikum Carl Gustav Carus

Phone: +49 7461 95

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Aesculap AG
Registry
ClinicalTrials.gov
Start date
7 October 2025
Est. completion
1 July 2027

Where this trial is recruiting

🇨🇿 Czechia 🇩🇪 Germany

Primary endpoints

Comparison of the surgical accuracy between the new OrthoPilot Software and the previous OrthoPilot Software

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov